Rxsight Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.4% | +0.3% | +66.8% | +1.6% | +2.6% | -1.7% | -1.3% | -0.2% | +1.1% | -2.5% | +16.0% | |
| – | +0.3% | +0.1% | +66.8% | +2.0% | +2.5% | -1.8% | -1.6% | +0.0% | +1.3% | -2.9% | +17.3% | |
| – | -1.7% | +236.8% | -25.1% | -31.6% | -0.1% | +67.6% | +44.1% | -26.6% | -32.7% | -11.9% | -24.0% | |
| – | -3.6% | -1.4% | +86.1% | +1.6% | +0.0% | -3.3% | -0.8% | +0.0% | +0.3% | -4.5% | -4.2% | |
| – | +33.0% | +6.3% | +19.4% | -1.4% | +18.5% | +3.0% | -9.4% | -13.9% | -3.2% | -4.0% | +249.9% | |
| – | -7.9% | +7.3% | +4.0% | +11.5% | +1.6% | +7.1% | +6.3% | +15.5% | +9.0% | +10.5% | +6.4% | |
| – | +8.9% | -13.3% | +57.5% | +9.6% | +12.4% | -9.6% | -8.1% | +5.1% | +11.0% | +1.6% | +143.5% | |
| – | +10.4% | -12.3% | +7.0% | +15.4% | +14.3% | -12.1% | -10.4% | +9.4% | +17.8% | +4.3% | +193.8% | |
| – | -8.9% | -10.4% | -54.4% | -0.3% | +32.7% | +8.3% | +4.4% | +17.4% | -10.1% | +29.4% | +10.6% | |
| – | -5.9% | +30.9% | +0.8% | -10.1% | -0.8% | +56.5% | -52.9% | +0.9% | +56.8% | +34.5% | -10.9% | |
| – | -0.7% | +2.2% | +67.9% | +0.7% | +1.4% | -0.7% | -0.5% | -0.7% | -0.1% | -3.0% | -1.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +2.5% | +4.4% | +3.5% | +1.4% | +0.4% | +0.6% | +0.5% | +0.5% | +0.3% | +0.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.